Skip to content. | Skip to navigation

Garvan Institute

 
Sections
 

Garvan Breakthroughs

2006 - Developed and commercialised a monoclonal antibody treatment for inflammatory diseases such as rheumatoid arthritis

Donate Now

Please help us continue our breakthrough medical research

Quick Facts

  • About two per cent of the Australian population is affected by rheumatoid arthritis
  • Children as young as three can be affected by rheumatoid arthritis


 

Arthritis Related News

 

Genes and disease

08 Jun 2007
News reports today detail the discovery of genetic regions that contribute to the risk of developing seven of the Western World's common diseases.
 
 

Clues to how diet might affect the immune system

02 Dec 2006
Garvan scientists are proposing that dietary fats can affect how well our immune system works and have discovered that one of the earliest steps in immune system activation relies on a molecule that binds fats.
 
 

Sydney scientists discover & license breakthrough anti-inflammatory treatment

08 Feb 2006
Scientists from the Garvan Institute of Medical Research have developed what could be the next big blockbuster treatment for inflammatory diseases such as rheumatoid arthritis and asthma.
 
 

Personal tools